26143 Time to scalp hair, eyebrow, and eyelash improvement in patients with alopecia areata treated with baricitinib in the phase 2 portion of the phase 2/3 BRAVE-AA1 study
2021
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI